US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

45.85

+1.673.79%

Post-market: 45.880.0344+0.08%18:07 EDT

Volume:2K

Turnover:95.66K

Market Cap:5.73M

PE:- -

High:45.88

Open:44.96

Low:44.81

Close:44.17

52wk High:45.88

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:1.06

T/O Rate:1.68%

Dividend:0.62

Dividend Rate:1.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

Political and General News Events from August 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/TBXU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":45.8456,"timestamp":1788379200000,"preClose":44.172,"halted":0,"volume":2099,"hourTrading":{"tag":"盘后","latestPrice":45.88,"preClose":45.8456,"latestTime":"18:07 EDT","volume":11,"amount":509.5236,"timestamp":1788386861384,"change":0.0344,"changeRate":0.00075,"amplitude":0},"delay":0,"changeRate":0.03788825500316944,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Not Yet Opened","change":1.6736,"latestTime":"09-02 16:00:00 EDT","open":44.96,"high":45.88,"low":44.81,"amount":95658.868856,"amplitude":0.024223,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":44.172,"sharesOutstanding":100001,"nav":44.235,"aum":5529447.64,"dividendRate":0.013563,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.88,"preClose":45.8456,"latestTime":"18:07 EDT","volume":11,"amount":509.5236,"timestamp":1788386861384,"change":0.0344,"changeRate":0.00075,"amplitude":0},"volumeRatio":1.059459},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.059459,"shares":125000,"dividePrice":0.6218,"high":45.88,"amplitude":0.024223,"preClose":44.172,"low":44.81,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":45.8456,"eps":0,"divideRate":0.013563,"volume":2099,"delay":0,"ttmEps":0,"open":44.96,"prevYearClose":31.065,"prevWeekClose":42.5761,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.3509,"twentyDayClose":35.755,"sixtyDayClose":29.6232},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IE00BJT1NW94.SGD","SG9999013999.USD","LU1585245621.USD","BK4588","EVLO","LU2468319806.SGD","BK4567","SG9999001176.USD","BK4581","LU1093756168.USD","BBH","LU0432979614.USD","GNMX","IE00B19Z9P08.USD","BIB","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4532","GNCAQ","IBB","LU0823416689.USD","IDNA","IE00B19Z3B42.SGD","LU2362541273.HKD","LU2089984988.USD","SGXZ57979304.SGD","IE00BZ9MQY76.HKD","LU0289739699.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1778281490.HKD","LU1093756325.SGD","VRTX","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE00B894F039.SGD","LU1035775433.USD","AMGN","LU0061475181.USD","LU0234570918.USD","IE0009355771.USD","IBBQ","BK4566","PBE","LU0079474960.USD","BK4599","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","IBBQ","LU1035775433.USD","LU1585245621.USD","IBB","LU2089984988.USD","LU2237438978.USD","LU0432979614.USD","LU2324357040.USD","BK4567","BIB","IE00B19Z3581.USD","IE0002141913.USD","LU1674673428.USD","LU2236285917.USD","IE0009355771.USD","LU1674673691.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU2362541513.USD","LU2468319806.SGD","PBE","IE00B894F039.SGD","BK4588","IE00BJT1NW94.SGD","IE0002270589.USD","LU1430594728.SGD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","BK4532","TBXU","SG9999001176.SGD","IE00B19Z9Z06.USD","VRTX","LU0320765992.SGD","GNMX","LU0417517546.SGD","LU1778281490.HKD","LU2456880835.USD","IE00B19Z9P08.USD","LU0289739699.SGD","IDNA","SGXZ57979304.SGD","BK4585","LU1093756168.USD","BBH","LU2417539215.USD","IE00B2B36J28.USD","BK4139","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNCR","XLV","IBB","FBT","BK4505","SYNB","LU0128526141.USD","LABU","IBBQ","MEMS","BK4588","XBI","CANC","BK4139","LEGN","TBXU","LU0029874061.USD","LFSC","GNOM","HCSG","MEDI","BK4585","BK4581","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU0345769631.USD","LU0158827781.USD","LU2063271972.USD","LU2552382058.USD","LU2211815571.USD","SG9999015341.SGD","LU2357627491.SGD","LU2430703095.HKD","IE00BWXC8680.SGD","LU2360106947.USD","SG9999014567.USD","LU0158827948.USD","LU0708995401.HKD","LU0823416689.USD","LU1868837300.USD","BK4559","LU1989772923.USD","LU2111349929.HKD","688235","IE00BN8TJ469.HKD","LU1236620834.HKD","LU1003077747.HKD","LU1244550221.USD","LU2433249047.HKD","MHIP","IE00BJLML261.HKD","LU1670627923.USD","LU2491050071.SGD","LU0316494557.USD","GLAM","LU1116320737.USD","LU1571399168.USD","LU0029864427.USD","LU1551013425.SGD","GSK.UK","LU0320765646.SGD","LU0211328371.USD","SG9999015978.USD","LU0980610538.SGD","BK7067","LU0477156953.USD","LU0994945656.USD","LU2168564495.EUR","LU0069063385.USD","IE00BJJMRY28.SGD","LU0345770993.USD","BIB","LU1061106388.HKD","LU1883839398.USD","LU0321505868.SGD","LU1585245621.USD","IE00BVYPNW00.USD","LU0795875086.SGD","LU1267930490.SGD","LU1934455194.USD","LU0170899867.USD","LU0006306889.USD","LU1988902786.USD","LU2347655073.USD","LU0234572021.USD","SGXZ51526630.SGD","LU0943347566.SGD","LU2089284900.SGD","LU1941712348.USD","LU2023250330.USD","LU1732800096.USD","LU2028103732.USD","IE00BFSS8Q28.SGD","LU1712237335.SGD","LU0072461881.USD","LU2362540622.SGD","LU1244550494.USD","LU1894683348.USD","LU2089283258.USD","LU2471134523.USD","IE000WAW04H5.SGD","LU1868836591.USD","LU2023251221.USD","IE000M9KFDE8.USD","TRUH","LU1868837136.USD","LU1280957306.USD","LU1894683264.USD","LU1829250122.USD","HRTS","LU0211327993.USD","SG9999002232.USD","LU0964807845.USD","LU2456880835.USD","LU2552382132.HKD","IE00BN29S564.USD","LU2361044949.HKD","LU2430703178.SGD","LU0823434740.USD","PBE","BK4550","LU1868836914.USD","LU0511384066.AUD","LU1074936037.SGD","IBBQ","BK4583","LU0122379950.USD","LU2271345857.HKD","GSKH","LU2125154778.USD","IYH","LU1057294990.SGD","LU2237443978.SGD","LU1261432733.SGD","SG9999015358.SGD","LU0426412945.USD","LU2505996681.GBP","LU0162691827.USD","LU0985481810.HKD","BK4581","LU0432979614.USD","LU2087621335.USD","LU0234570918.USD","LLYX","LU0154236417.USD","SG9999001176.USD","LLY","LU0889566641.SGD","LLYZ","LU2471134879.HKD","LU0323591593.USD","LU1629891620.HKD","LU2168564222.USD","SG9999014880.SGD","IE00BKVL7J92.USD","LU0868494708.USD","LU2237443465.HKD","LU2491049909.HKD","LU2361045086.USD","LU1064131342.USD","LU0225284248.USD","LU1496350171.SGD","LU2129689431.USD","IE0004445015.USD","LU0203345920.USD","LU0289739343.SGD","LU1232071149.USD","LU2237443549.SGD","LU2112291526.USD","LU2133065610.SGD","LU0133085943.USD","LU1929549753.HKD","LU1032466523.USD","LU2430703251.USD","LU2237438978.USD","LU2746668974.SGD","OZEM","VHT","LU0354030511.USD","LU0208291251.USD","LU2125909247.SGD","PAWZ","LU2347655156.SGD","SG9999014898.SGD","LU2236285917.USD","LU0070217475.USD","RXL","LU1430594728.SGD","AZN","LU1196500208.SGD","IE0005OL40V9.USD","BK4007","LU0070302665.USD","IE00BSNM7G36.USD","LU1221951046.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","LU0689472784.USD","NVOX","LU1267930573.SGD","LU0130517989.USD","LU2746668461.USD","LU2168564065.EUR","LU2471134952.CNY","LU1814569148.SGD","THNR","IE00B775H168.HKD","LU1934455863.HKD","SG9999018865.SGD","LU2237443895.HKD","LU0471298694.HKD","LU2750360641.GBP","JNJ","LU0174119429.USD","LU2213496289.HKD","LU2602419157.SGD","LU0266013472.USD","LU1983299246.USD","LU0320765489.SGD","LU2552382215.SGD","LU0289739699.SGD","NVOH","IE0002270589.USD","PFE","LU1868836757.USD","LU1116320901.HKD","LU1718418525.SGD","LU2023250843.SGD","LU1720051017.SGD","LU1914381329.SGD","LU0471298777.SGD","IHE","GB00BDT5M118.USD","LU1804176565.USD","LU2264538146.SGD","IE00BBT3K403.USD","LU2596442595.SGD","LU0096364046.USD","NVOC","BK0239","LU0949170772.SGD","BMED","BK4599","LU2108987350.USD","SG9999001440.SGD","LU1043141396.HKD","IBB","FTXH","LU0306807586.USD","IE00B2B36J28.USD","SG9999001176.SGD","LU1066051811.HKD","SG9999017495.SGD","LU2361044865.SGD","IE00B42XCP33.USD","WDNA","LU0210536198.USD","GDOC","BK4504","LU2129689514.USD","LU0965509010.AUD","LU1066051225.USD","LU1267930813.SGD","LU1228905037.USD","LU2362541273.HKD","BK7511","IE00BK4W5L77.USD","LU0472753341.HKD","LU1127390331.HKD","BBIO","PJP","LU0545039389.USD","LU2242652126.USD","LU1674673691.USD","LU1059921491.USD","LU1069344957.HKD","LU2750360997.AUD","BK4585","LU0225283273.USD","LU0238689110.USD","LU1023059063.AUD","BBH","LU0823434583.USD","LU0861579265.USD","LU1974910355.USD","SG9999015986.USD","LU1035775433.USD","LU1236620750.USD","IE000BZT7R73.USD","LU2168563687.JPY","LU0061475181.USD","LU0310800379.SGD","SG9999014906.USD","LU2462157665.USD","LU0395794307.EUR","LU0672654240.SGD","LU2491050154.USD","REGN","LU2360032135.SGD","SG9999014914.USD","SG9999003800.SGD","LU0128525929.USD","LU2487616109.SGD","LU2471134796.USD","ILDR","LU1670711123.USD","LU0889565916.HKD","LU0321505439.SGD","LU1069347547.HKD","MRK","IE00BLSP4239.USD","NVO","LU2403377893.USD","LU2461242641.AUD","LU1778281490.HKD","LU0058720904.USD","LU2237443382.USD","LU2125154935.USD","ELIL","IE00BKDWB100.SGD","LU1720051108.HKD","LU0109394709.USD","BK7501","LU0203202063.USD","LU0738911758.USD","ABBV","BK4566","LU1674673428.USD","LU1093756168.USD","LU2324357040.USD","04332","LU1496350502.SGD","SG9999013999.USD","LU0079474960.USD","LU1145028129.USD","LU1941712264.USD","LU1093756325.SGD","IE00B1XK9C88.USD","BK4534","SG9999011175.SGD","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","IE00BKPKM429.USD","BK4505","IE00BFSS7M15.SGD","LU0210528500.USD","IE0004445239.USD","ONC","LU0114720955.EUR","LU0553294199.USD","LU0882574055.USD","LU0320765992.SGD","LU2505996509.AUD","IE00B4R5TH58.HKD","LU1691799644.USD","IE00BFXG1179.USD","LU0965509283.SGD","CANC","LU1037948541.HKD","LU1934455277.USD","LU0097036916.USD","LU1066051498.USD","SG9999014542.SGD","LU1935042991.SGD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU1839511570.USD","LU0320765059.SGD","IE00B3T34201.USD","LU0708994859.HKD","MEDI","PPH","SGXZ31699556.SGD","LU0726765562.USD","LU0109391861.USD","LU0820562030.AUD","BK4516","SG9999014575.USD","LU2087625088.SGD","MEDX","SG9999015945.SGD","LU0985320562.USD","LU0124676726.USD","LU2417539215.USD","LU1623119135.USD","LU0353189763.USD","LU0689626769.HKD","LU2756315318.SGD","LU0267386448.USD","IE000SO60NU8.SGD","IE00BJJMRX11.SGD","LU2106854487.HKD","LU2125909593.SGD","LU1035773651.USD","LU0198837287.USD","NVS","AZNH","LU0211331839.USD","LU0820561818.USD","LU0094547139.USD","LU0057025933.USD","LU1291159041.SGD","LU1366192091.USD","IE00B3PB1722.GBP","IE00B4JS1V06.HKD","LU2168564149.EUR","LU0265550946.USD","BK7508","LU1917777945.USD","SGXZ80539844.SGD","LU0203347892.USD","LU2592432038.USD","LU1066053197.SGD","LU0456855351.SGD","LU0417517546.SGD","LU1989771016.USD","LU1032955483.USD","IE0002141913.USD","GSK","LU1923622614.USD","LU0545562505.USD","BK4578","IXJ","LU1506573853.SGD","SGXZ99366536.SGD","LU0130102774.USD","LU1228905540.USD","LU0354030438.USD","LU0942090050.USD","IE0009355771.USD","JDOC","LU0098860793.USD","LU0661504455.SGD","LU1548497426.USD","LU0106261372.USD","LU0820561909.HKD","IE00B19Z3B42.SGD","TBXU","LU2089984988.USD","LU0640476718.USD","LU0868494617.USD","LU0795875169.SGD","LU1323610961.USD","CSL.AU","IE00B7SZLL34.SGD","LU1162221912.USD","LU2357305700.SGD","LU1699723380.USD","LU0256863811.USD","SGXZ81514606.USD","SG9999015952.SGD","IE00B19Z3581.USD","BK4533","IE00BVYPNV92.GBP","LU0306806265.USD","LU2468319806.SGD","LU0466842654.USD","BK4588","IE0034235303.USD","LU0053666078.USD","AMGN","GILD","LU1267930730.SGD","LU2462591350.SGD","LU0310799852.SGD","LU0882574139.USD","LU0965508806.USD","LU1221951129.SGD","LU1989772840.SGD","LU0203201768.USD","IE00BJT1NW94.SGD","IE0001KFT4U8.USD","LU2362541513.USD","LU1670628061.USD","LU0912757837.SGD","LU0792757196.USD","IE0000B7K699.USD","LU0256863902.USD","LU2896262040.SGD","LU0426417589.USD","XLV","BK4568","LU1121112475.USD","BMY","BK4532","LU1551013342.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SG9999018857.SGD","LU0786609619.USD","LU0225771236.USD","LU2756315664.SGD","LU1670711040.USD","BK4592","06160","IE00B7KXQ091.USD","LU0859254822.USD","LU1244550577.SGD","LU1979441026.SGD","LU0345770308.USD","LU0289961442.SGD","LU0345769128.USD","LU2023250504.SGD","LU0648001328.SGD","LLII","SG9999014559.SGD","BK4139","LU1201861249.SGD","LU0385154629.USD","LU2242646821.SGD","LU1670710588.SGD","LU1670710661.SGD","LU1043141123.HKD","AGNG","LU0353189680.USD","LU0965509101.SGD","ELIS","IE000MB6IJN5.SGD","LU2237443622.USD","FHLC","TMED","LU2129689605.HKD","LU1732799900.SGD","LU0237698245.USD","LU2265009873.SGD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU0787776722.HKD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1571399168.USD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU0109394709.USD","SG9999001440.SGD","BK4588","BK4534","BK4566","LU0868494617.USD","LU0058720904.USD","LU1983299246.USD","BK4533","IE0002141913.USD","LU2242652126.USD","BK4585","BBH","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","TBXU","LU0289739699.SGD","BIB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IBBQ","PJP","LU1061106388.HKD","LU2089984988.USD","LU2112291526.USD","BK4599","LU2242646821.SGD","AMGN","BK4581","LU2468319806.SGD","IBB","PBE","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","IE00BFTCPJ56.SGD","SYNB","BK4532","MEDX","BK4578","LU0320765489.SGD","FBT","BK4007","BMED","IE0002141913.USD","IE0009355771.USD","IBB","BK4588","NVIB","GDOC","TBXU","IDNA","NVS","PPH","GNOM","HYLG","BK4585","IE00BJT1NW94.SGD","CNCR","IE00B2B36J28.USD","LU0070302665.USD","LFSC","LU0211331839.USD","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004091025.USD","BK4127","BK4504","IE0002270589.USD","LU0345770993.USD","LU0417517546.SGD","LU2471134879.HKD","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","IE0034235188.USD","IE00B19Z3581.USD","LU0868494708.USD","TBXU","LU2362541513.USD","LU1430594728.SGD","IE0002141913.USD","GSX","LU0757428866.USD","LU0106831901.USD","IBBQ","LU2471134952.CNY","BBH","LU2237443382.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","IE00BSNM7G36.USD","LU2236285917.USD","LU1815336091.USD","LU2089984988.USD","VERX","BIB","IE00B894F039.SGD","IDNA","LU2237443895.HKD","LU0432979614.USD","LU1668664300.SGD","IE00BJT1NW94.SGD","VRTX","LU1868836914.USD","LU2362540622.SGD","LU1093756325.SGD","GNMX","PBE","LU2471134796.USD","SGXZ57979304.SGD","LU1035775433.USD","LU1894683264.USD","LU1778281490.HKD","IBB","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMGN","BK4599","IE00B2B36J28.USD","BK4585","LU2089984988.USD","LU0289739699.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","BK4588","LU2468319806.SGD","PJP","LU1571399168.USD","BK4566","BK4581","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4533","IBB","IBBQ","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1983299246.USD","TBXU","BBH","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","BK4139","BIB","PBE","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMGN","BK4599","IE00B2B36J28.USD","BK4585","LU2089984988.USD","LU0289739699.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","BK4588","LU2468319806.SGD","PJP","LU1571399168.USD","BK4566","BK4581","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4533","IBB","IBBQ","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1983299246.USD","TBXU","BBH","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","BK4139","BIB","PBE","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","IBBQ","SG9999001176.USD","PBE","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2456880835.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU1430594728.SGD","ACKY","IDNA","BRKW","IE00B19Z9P08.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1778281490.HKD","BRKD","GNMX","ACTV","IBB","LU0109394709.USD","BK4139","BRKL","LU0889565916.HKD","LU2362541513.USD","VERX","LU0061475181.USD","LU1559883803.SGD","LU1069344957.HKD","LU1674673428.USD","VRTX","LU1815336091.USD","BK4567","LU2462157665.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE00BFTCPJ56.SGD","BBH","BIB","LU0757428866.USD","BRKC","TBXU","BRKU","LU2237438978.USD","BK4588","IE0002141913.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IE0009355771.USD","LU0061475181.USD","IE00B19Z3B42.SGD","SG9999001176.USD","VRTX","BK4585","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2417539215.USD","PBE","IE00B19Z3581.USD","BBH","BK4532","BIB","GNMX","LU1069344957.HKD","TBXU","BK4588","VERX","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","LU1778281490.HKD","LU0823416689.USD","LU2089984988.USD","IBBQ","LU0234570918.USD","LU2324357040.USD","LU1674673691.USD","LU0432979614.USD","IE00B19Z9Z06.USD","CDIG","SG9999001176.SGD","LU1430594728.SGD","LU1559883803.SGD","LU2362540622.SGD","SGXZ57979304.SGD","LU0566484027.USD","LU1035775433.USD","LU0109394709.USD","LU1674673428.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0079474960.USD","IBB","TSPA","TACU","IDNA","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0053666078.USD","LU0114720955.EUR","LU1917777945.USD","LU2089984988.USD","LU2362540622.SGD","LU2106854487.HKD","LU0058720904.USD","LU0109394709.USD","ARTY","LU0320765992.SGD","BK4585","AIPO","LU0882574055.USD","TBXU","LU1974910355.USD","VTHR","LU0823416689.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD","REGN","LU2362541513.USD","LU0823434740.USD","LU0289739699.SGD","LU0889565916.HKD","LU2023250504.SGD","BK4195","CHAT","LU2362541273.HKD","HBCP","IBBQ","IBB","AGIX","BK4211","BBH","BK4139","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2468319806.SGD","PJP","TBXU","BK7511","LU1983299246.USD","IE00BBT3K403.USD","IE00BJT1NW94.SGD","BK4007","PFE","PBE","688235","SGXZ57979304.SGD","IE0002270589.USD","LU0321505439.SGD","AMGN","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0889565916.HKD","BIB","SG9999001176.SGD","BK4566","IONS","LU0225284248.USD","LU0868494617.USD","SG9999002224.SGD","CSL.AU","LU2242646821.SGD","BK4505","BK4550","IE00BLSP4452.SGD","IE00B3T34201.USD","IBB","IE0002141913.USD","BBIO","BK0012","BK0046","LU1883839398.USD","LU0306806265.USD","IBBQ","BBH","OZEM","IE00BLSP4239.USD","LU1057294990.SGD","BK0028","300485","LU0320765992.SGD","LU0109394709.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4505","BK4585","LFSC","IE0009354923.USD","BK4588","GNOM","TBXU","IBB","RNA","SYNB","FBT","IBBQ","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","LU2089984988.USD","LU0868494617.USD","LU0109394709.USD","LU0289739699.SGD","LU0122379950.USD","SG9999001440.SGD","IBB","LU1057294990.SGD","IE00BJJMRZ35.SGD","PJP","IE00BFTCPJ56.SGD","LU1023059063.AUD","IE00B2B36J28.USD","BBH","LU1983299246.USD","BK4588","TBXU","IE0009355771.USD","BK4566","BK4534","LU1571399168.USD","BK4139","IBBQ","BK4599","BK4585","AMGN","LU1061106388.HKD","LU2242652126.USD","BIB","IE00BJT1NW94.SGD","LU0889565916.HKD","PBE","LU2112291526.USD","IE0002141913.USD","BK4581","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4533","LU0889565916.HKD","IBB","BK4585","IE0002141913.USD","PBE","BK4581","AMGN","LU0109394709.USD","BK4139","LU1983299246.USD","BK4566","IE00BJT1NW94.SGD","SG9999001440.SGD","LU2242646821.SGD","PJP","IE00B4R5TH58.HKD","LU2089984988.USD","LU1023059063.AUD","IBBQ","BIB","LU0868494617.USD","TBXU","IE00BFTCPJ56.SGD","BBH","LU1061106388.HKD","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","LU1571399168.USD","LU0122379950.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0289739699.SGD","BK4534","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2242652126.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","PJP","BK4599","LU1023059063.AUD","BK4588","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU2112291526.USD","BIB","IBBQ","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","BK4534","LU0889565916.HKD","IBB","LU1983299246.USD","LU2242652126.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","BK4566","BK4533","LU0320765992.SGD","BK4139","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","PBE","IE00B4R5TH58.HKD","AMGN","LU0122379950.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0058720904.USD","LU2112291526.USD","LU2468319806.SGD","LU1061106388.HKD","PJP","BK4139","BK4588","LU1057294990.SGD","LU1983299246.USD","SG9999001440.SGD","BBH","BK4534","AMGN","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2242652126.USD","LU0889565916.HKD","LU0868494617.USD","BK4581","IBBQ","LU0122379950.USD","IE0009355771.USD","LU2242646821.SGD","BK4533","PBE","IE00BJJMRZ35.SGD","BK4585","LU2089984988.USD","IE0002141913.USD","TBXU","LU1571399168.USD","LU1023059063.AUD","IE00B2B36J28.USD","IBB","BK4599","BIB","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","BBP","IEIH","FRTY","LABU","XLVX","IYH","MEDI","MRNX","LFSC","IDNA","SYNB","RSPH","GDOC","GNMX","PTGX","TAK","IBB","BK4139","MRNY","BMED","PINK","BK4585","BK4007","NVIB","TBXU","BK4588","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","LU0114720955.EUR","LU1066051498.USD","LU1934455863.HKD","BK4578","BK4568","LU2468319806.SGD","BMED","LU0965508806.USD","MEDI","IE00B3T34201.USD","LU0234570918.USD","TBXU","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1023059063.AUD","LU1839511570.USD","LU1934455277.USD","LU2324357040.USD","BBH","BK4585","SG9999015945.SGD","IBB","GILD","LU0109394709.USD","LU0882574055.USD","LU1066053197.SGD","LU0823416689.USD","IE00BKVL7J92.USD","BK4583","IE00B19Z3B42.SGD","LU0965509283.SGD","LU1061106388.HKD","BIB","LU2112291526.USD","LU0122379950.USD","BK4532","LU1430594728.SGD","IBBQ","BK4550","TMED","BK4139","BK4588","SG9999015978.USD","LU1934455194.USD","LU1585245621.USD","LU1571399168.USD","LU0058720904.USD","LU2089984988.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}